Eating spicy foods regularly may extend lifespan
the ONA take:
Eating spicy foods regularly may lower the risk of death from cancer, ischemic disease, and respiratory disease, according to a new observational study published in The BMJ.
For the study, researchers in China analyzed data from a prospective cohort study that included 487,375 adults from various various in China. All participants were between ages 30 and 70 and completed questionnaires about their health and consumption of red meat, vegetables, alcohol, and spicy foods. Participants were followed for an average of 7.2 years.
Results showed that consumption of spicy food 3 to 7 days a week was associated with a 14% reduced risk of death during the follow-up period compared with participants who consumed spicy foods less than once a week. Eating spicy foods once or twice a week was linked with a 10% reduced risk of death compared with those who ate it less than once a week.
Researchers also found that frequent consumption of spicy foods was associated with a reduced risk of death from cancer, ischemic heart disease, and respiratory diseases. This effect was more strongly observed in women than men.
Eating spicy foods regularly may lower the risk of death from cancer, ischemic disease, and respiratory disease.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|